Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Francque

Showing results (1-10 of 177) with videos related to

Pageof 18
Sort By:
JHEP Reports : Innovation in Hepatology|June 6, 2020
Innovative liver research continues during the current pandemicSven Francque
Hepatology (Baltimore, Md.)|June 23, 2021
Saroglitazar for the Treatment of NASH: The Peroxisome Proliferator-Activated Receptor Story Goes On!Sven Francque
Journal of the American Heart Association|April 13, 2021
The Liver and the Cardiovascular System: Two of a Kind?Sven Francque
Expert Review of Gastroenterology & Hepatology|September 2, 2017
The future of diagnosing NASH - could a simple blood test be the key?Sven Francque, Luisa Vonghia
Advances in Therapy|March 20, 2019
Pharmacological Treatment for Non-alcoholic Fatty Liver DiseaseSven Francque, Luisa Vonghia
Hepatology (Baltimore, Md.)|August 6, 2019
Noninvasive Tests of Liver Fibrosis and Their Combination in Nonalcoholic Fatty Liver Disease: From Selected Patients to Real-Life PopulationsJérôme Boursier, Sven Francque
World Journal of Hepatology|August 6, 2015
Cross talk of the immune system in the adipose tissue and the liver in non-alcoholic steatohepatitis: Pathology and beyondLuisa Vonghia, Sven Francque
Clinics in Liver Disease|April 6, 2023
Future Treatment Options and Regimens for Nonalcoholic Fatty Liver DiseaseSven Francque, Vlad Ratziu
International Journal of Molecular Sciences|October 3, 2013
Immunological mechanisms in the pathophysiology of non-alcoholic steatohepatitisLuisa Vonghia, Peter Michielsen, Sven Francque
Journal of Hepatology|May 19, 2022
Breakthroughs in therapies for NASH and remaining challengesVlad Ratziu, Sven Francque, Arun Sanyal
Pageof 18

Showing results (1-10 of 177) with videos related to

Sort By:
Pageof 18
JHEP Reports : Innovation in Hepatology|June 6, 2020
Innovative liver research continues during the current pandemicSven Francque
Hepatology (Baltimore, Md.)|June 23, 2021
Saroglitazar for the Treatment of NASH: The Peroxisome Proliferator-Activated Receptor Story Goes On!Sven Francque
Journal of the American Heart Association|April 13, 2021
The Liver and the Cardiovascular System: Two of a Kind?Sven Francque
Expert Review of Gastroenterology & Hepatology|September 2, 2017
The future of diagnosing NASH - could a simple blood test be the key?Sven Francque, Luisa Vonghia
Advances in Therapy|March 20, 2019
Pharmacological Treatment for Non-alcoholic Fatty Liver DiseaseSven Francque, Luisa Vonghia
Hepatology (Baltimore, Md.)|August 6, 2019
Noninvasive Tests of Liver Fibrosis and Their Combination in Nonalcoholic Fatty Liver Disease: From Selected Patients to Real-Life PopulationsJérôme Boursier, Sven Francque
World Journal of Hepatology|August 6, 2015
Cross talk of the immune system in the adipose tissue and the liver in non-alcoholic steatohepatitis: Pathology and beyondLuisa Vonghia, Sven Francque
Clinics in Liver Disease|April 6, 2023
Future Treatment Options and Regimens for Nonalcoholic Fatty Liver DiseaseSven Francque, Vlad Ratziu
International Journal of Molecular Sciences|October 3, 2013
Immunological mechanisms in the pathophysiology of non-alcoholic steatohepatitisLuisa Vonghia, Peter Michielsen, Sven Francque
Journal of Hepatology|May 19, 2022
Breakthroughs in therapies for NASH and remaining challengesVlad Ratziu, Sven Francque, Arun Sanyal
Pageof 18